Akira Nakagawara

Title: Akira Nakagawara: Innovator in Neurotrophic Factor Research

Introduction

Akira Nakagawara is a prominent inventor based in Philadelphia, PA (US). She has made significant contributions to the field of neurotrophic factors, particularly through her innovative research and patent work. Her dedication to advancing medical science is evident in her groundbreaking discoveries.

Latest Patents

Akira Nakagawara holds a patent for "Compositions and methods of making and using human full length TRK-B." This patent discloses the amino acid sequence of the full-length version of the human neurotrophic factor receptor TRK B, along with a nucleotide sequence encoding it. The patent also includes transformed host cells and transgenic animals containing nucleic acid molecules that encode full-length human TRK-B. Additionally, it covers probes, primers, and antisense molecules that are identical and complementary to the nucleotide sequence encoding full-length human TRK-B, particularly the intracellular portion of the receptor. Furthermore, monoclonal antibodies that bind to the full-length human TRK-B protein are disclosed, along with methods of using and kits that include these probes, primers, antisense molecules, and monoclonal antibodies.

Career Highlights

Akira Nakagawara is affiliated with The Children's Hospital of Philadelphia, where she continues her research and development efforts. Her work has been instrumental in advancing the understanding of neurotrophic factors and their applications in medicine.

Collaborations

One of her notable collaborators is Garrett M Brodeur, who has worked alongside her in various research initiatives. Their combined expertise has contributed to significant advancements in their field.

Conclusion

Akira Nakagawara's contributions to neurotrophic factor research and her innovative patent work highlight her role as a leading inventor in the medical field. Her ongoing efforts continue to pave the way for future advancements in healthcare.